Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone in Patients With IgA-nephropathy
NCT07056595Recruiting
- Sponsor
- Botkin Hospital
- Start
- May 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of finerenone in IgA nephropathy (IgAN), sponsored by Botkin Hospital. Started May 2025; status: recruiting.
02
Drugs
finerenone
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT07056595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07056595.